Volume 7, supplément 1, Supplement 1, September 2005

Introduction

The modern challenges of drug resistant epilepsy (p.1-2)
Philippe Ryvlin
Article offert

Global care of patients with drug resistant epilepsy

Mechanisms of drug resistance (p.3-9)
Wolfgang Löscher
Article offert

Can we predict refractory epilepsy at the time of diagnosis? (p.10-3)
Franck Semah, Philippe Ryvlin
Article offert

Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs (p.14-21)
Emilio Perucca
Article offert

VNS Therapy versus the latest antiepileptic drug (p.22-6)
Elinor Ben-Menachem, Jacqueline A. French
Article offert

Improving quality of life beyond seizure control (p.34-8)
Steven C Schachter
Article offert

The impact of epilepsy surgery on mortality (p.39-46)
Philippe Ryvlin, Alexandra Montavont, Philippe Kahane
Article offert

Gobal care of patients with drug resistant epilepsy

Epilepsy and common comorbidities: improving the outpatient epilepsy encounter (p.27-33)
Frank G Gilliam, Anil Mendiratta, Alison M Pack, Carl W Bazil
Article offert